non-recirculating constant flow langendorff apparatus Search Results


non-recirculating constant flow langendorff apparatus  (Harvard Bioscience)
90
Harvard Bioscience non-recirculating constant flow langendorff apparatus
Non Recirculating Constant Flow Langendorff Apparatus, supplied by Harvard Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-recirculating+constant+flow+langendorff+apparatus/langendorff+apparatus/pmc06180127__41598_2018_33144_MOESM1_ESM-47-14-20
Average 90 stars, based on 1 article reviews
non-recirculating constant flow langendorff apparatus - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
langendorff heart perfusion apparatus  (Radnoti LLC)
90
Radnoti LLC langendorff heart perfusion apparatus
Langendorff Heart Perfusion Apparatus, supplied by Radnoti LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-recirculating+constant+flow+langendorff+apparatus/langendorff+apparatus/pm09463631-32-9-14
Average 90 stars, based on 1 article reviews
langendorff heart perfusion apparatus - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
langendorff constant pressure non-recirculating system  (Radnoti LLC)
90
Radnoti LLC langendorff constant pressure non-recirculating system
Experimental design for CORM-2-mediated cardioprotection and role of various kinases. The isolated, <t>Langendorff-perfused</t> rat hearts were stabilised for 10 min, perfused for 15 min with K–H buffer. Hearts were treated with Vehicle or iCORM-2 (inactive form of CORM) or CORM-2 (50 μM) (a, b and c). The treatment with various inhibitors like SCIO-469 (1 μM) or SB-203580 (10 μM) or chelerythrine (10 μM) or wortmannin (100 nM) was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment followed by 30 min of global ischaemia and 120 min of reperfusion (d, e and f). Some hearts (g, h and i) pretreated with CORM-2 and 100 nM wortmannin, the treatment with wortmannin was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment and throughout reperfusion.
Langendorff Constant Pressure Non Recirculating System, supplied by Radnoti LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-recirculating+constant+flow+langendorff+apparatus/langendorff+constant+pressure+non+recirculating+system/pmc03630723-21-20-25
Average 90 stars, based on 1 article reviews
langendorff constant pressure non-recirculating system - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
non-recirculation langendorff perfusion apparatus  (Radnoti LLC)
90
Radnoti LLC non-recirculation langendorff perfusion apparatus
Experimental design for CORM-2-mediated cardioprotection and role of various kinases. The isolated, <t>Langendorff-perfused</t> rat hearts were stabilised for 10 min, perfused for 15 min with K–H buffer. Hearts were treated with Vehicle or iCORM-2 (inactive form of CORM) or CORM-2 (50 μM) (a, b and c). The treatment with various inhibitors like SCIO-469 (1 μM) or SB-203580 (10 μM) or chelerythrine (10 μM) or wortmannin (100 nM) was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment followed by 30 min of global ischaemia and 120 min of reperfusion (d, e and f). Some hearts (g, h and i) pretreated with CORM-2 and 100 nM wortmannin, the treatment with wortmannin was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment and throughout reperfusion.
Non Recirculation Langendorff Perfusion Apparatus, supplied by Radnoti LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-recirculating+constant+flow+langendorff+apparatus/non+circulating+langendorff+apparatus/us07985771-1262-16-20
Average 90 stars, based on 1 article reviews
non-recirculation langendorff perfusion apparatus - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
modified nonrecirculating langendorff perfusion system anton paar  (Anton Paar)
90
Anton Paar modified nonrecirculating langendorff perfusion system anton paar
Experimental design for CORM-2-mediated cardioprotection and role of various kinases. The isolated, <t>Langendorff-perfused</t> rat hearts were stabilised for 10 min, perfused for 15 min with K–H buffer. Hearts were treated with Vehicle or iCORM-2 (inactive form of CORM) or CORM-2 (50 μM) (a, b and c). The treatment with various inhibitors like SCIO-469 (1 μM) or SB-203580 (10 μM) or chelerythrine (10 μM) or wortmannin (100 nM) was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment followed by 30 min of global ischaemia and 120 min of reperfusion (d, e and f). Some hearts (g, h and i) pretreated with CORM-2 and 100 nM wortmannin, the treatment with wortmannin was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment and throughout reperfusion.
Modified Nonrecirculating Langendorff Perfusion System Anton Paar, supplied by Anton Paar, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-recirculating+constant+flow+langendorff+apparatus/modified+nonrecirculating+langendorff+perfusion+system+anton+paar/pm12652102-48-13-17
Average 90 stars, based on 1 article reviews
modified nonrecirculating langendorff perfusion system anton paar - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Experimental design for CORM-2-mediated cardioprotection and role of various kinases. The isolated, Langendorff-perfused rat hearts were stabilised for 10 min, perfused for 15 min with K–H buffer. Hearts were treated with Vehicle or iCORM-2 (inactive form of CORM) or CORM-2 (50 μM) (a, b and c). The treatment with various inhibitors like SCIO-469 (1 μM) or SB-203580 (10 μM) or chelerythrine (10 μM) or wortmannin (100 nM) was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment followed by 30 min of global ischaemia and 120 min of reperfusion (d, e and f). Some hearts (g, h and i) pretreated with CORM-2 and 100 nM wortmannin, the treatment with wortmannin was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment and throughout reperfusion.

Journal: Indian Journal of Pharmaceutical Sciences

Article Title: Mechanism(s) Involved in Carbon Monoxide-releasing Molecule-2-mediated Cardioprotection During Ischaemia-reperfusion Injury in Isolated Rat Heart

doi: 10.4103/0250-474X.107047

Figure Lengend Snippet: Experimental design for CORM-2-mediated cardioprotection and role of various kinases. The isolated, Langendorff-perfused rat hearts were stabilised for 10 min, perfused for 15 min with K–H buffer. Hearts were treated with Vehicle or iCORM-2 (inactive form of CORM) or CORM-2 (50 μM) (a, b and c). The treatment with various inhibitors like SCIO-469 (1 μM) or SB-203580 (10 μM) or chelerythrine (10 μM) or wortmannin (100 nM) was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment followed by 30 min of global ischaemia and 120 min of reperfusion (d, e and f). Some hearts (g, h and i) pretreated with CORM-2 and 100 nM wortmannin, the treatment with wortmannin was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment and throughout reperfusion.

Article Snippet: Isolated heart was cannulated via aorta and perfused in the Langendorff's mode at constant perfusion pressure 70 mmHg using Radnoti Langendorff constant pressure non-recirculating system (Radnoti glass technology Inc., CA, USA).

Techniques: Isolation